Willis Investment Counsel’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.7M | Hold |
151,800
| – | – | 1.62% | 22 |
|
|
2025
Q4 | $26.3M | Hold |
151,800
| – | – | 1.36% | 24 |
|
|
2025
Q3 | $28.9M | Buy |
151,800
+14,900
| +11% | +$2.64M | 1.58% | 19 |
|
|
2025
Q2 | $24.6M | Buy |
136,900
+16,800
| +14% | +$2.92M | 1.44% | 24 |
|
|
2025
Q1 | $20.3M | Hold |
120,100
| – | – | 1.37% | 31 |
|
|
2024
Q4 | $18.1M | Hold |
120,100
| – | – | 1.19% | 38 |
|
|
2024
Q3 | $18.6M | Sell |
120,100
-16,200
| -12% | -$2.42M | 1.21% | 36 |
|
|
2024
Q2 | $18.7M | Hold |
136,300
| – | – | 1.29% | 32 |
|
|
2024
Q1 | $18.1M | Hold |
136,300
| – | – | 1.25% | 32 |
|
|
2023
Q4 | $18.8M | Sell |
136,300
-500
| -0.4% | -$65.7K | 1.32% | 28 |
|
|
2023
Q3 | $16.7M | Hold |
136,800
| – | – | 1.26% | 30 |
|
|
2023
Q2 | $19.2M | Hold |
136,800
| – | – | 1.25% | 30 |
|
|
2023
Q1 | $19.4M | Hold |
136,800
| – | – | 1.26% | 28 |
|
|
2022
Q4 | $21.4M | Hold |
136,800
| – | – | 1.37% | 25 |
|
|
2022
Q3 | $16.8M | Sell |
136,800
-19,800
| -13% | -$2.61M | 1.22% | 34 |
|
|
2022
Q2 | $20.8M | Sell |
156,600
-21,200
| -12% | -$2.89M | 1.28% | 29 |
|
|
2022
Q1 | $24.3M | Sell |
177,800
-3,600
| -2% | -$502K | 1.29% | 29 |
|
|
2021
Q4 | $31.4M | Sell |
181,400
-4,800
| -3% | -$730K | 1.65% | 20 |
|
|
2021
Q3 | $27.1M | Sell |
186,200
-3,700
| -2% | -$541K | 1.55% | 21 |
|
|
2021
Q2 | $25.1M | Sell |
189,900
-1,600
| -0.8% | -$209K | 1.48% | 25 |
|
|
2021
Q1 | $24.6M | Sell |
191,500
-1,700
| -0.9% | -$209K | 1.49% | 25 |
|
|
2020
Q4 | $23M | Sell |
193,200
-100
| -0.1% | -$12.2K | 1.57% | 26 |
|
|
2020
Q3 | $22.1M | Sell |
193,300
-29,800
| -13% | -$3.52M | 1.98% | 19 |
|
|
2020
Q2 | $25.4M | Sell |
223,100
-4,800
| -2% | -$509K | 1.97% | 14 |
|
|
2020
Q1 | $18.3M | Sell |
227,900
-500
| -0.2% | -$51.8K | 1.52% | 25 |
|
|
2019
Q4 | $24.4M | Hold |
228,400
| – | – | 1.58% | 33 |
|
|
2019
Q3 | $24.4M | Buy |
228,400
+17,200
| +8% | +$1.77M | 1.64% | 29 |
|
|
2019
Q2 | $21.5M | Buy |
211,200
+164,213
| +349% | +$15.8M | 1.46% | 33 |
|
|
2019
Q1 | $6.67M | Buy |
46,987
+6,387
| +16% | +$553K | 0.46% | 74 |
|
|
2018
Q4 | $3.38M | Buy |
+40,600
| New | +$3.81M | 0.25% | 92 |
|
|
2017
Q4 | – | Sell |
-27,200
| Closed | -$2.55M | – | 120 |
|
|
2017
Q3 | $2.55M | Sell |
27,200
-800
| -3% | -$84.9K | 0.18% | 100 |
|
|
2017
Q2 | $3.11M | Buy |
+28,000
| New | +$2.96M | 0.24% | 96 |
|
|
2016
Q3 | – | Sell |
-44,100
| Closed | -$3.59M | – | 126 |
|
|
2016
Q2 | $3.59M | Sell |
44,100
-83,400
| -65% | -$6.35M | 0.31% | 97 |
|
|
2016
Q1 | $9.11M | Buy |
127,500
+7,900
| +7% | +$530K | 0.8% | 60 |
|
|
2015
Q4 | $8.51M | Buy |
119,600
+88,200
| +281% | +$5.93M | 0.77% | 57 |
|
|
2015
Q3 | $1.93M | Buy |
+31,400
| New | +$2.19M | 0.19% | 106 |
|
Other funds holding DGX
VCM
VPM
EIG
Willis Investment Counsel's DGX Position: Q1 2026 in Review
Willis Investment Counsel held its Quest Diagnostics (DGX) position steady in Q1 2026 at 151,800 shares worth $29.7M. The position accounts for 1.62% of the portfolio, ranked #22.
Willis Investment Counsel first reported a position in DGX in Q3 2015 and has held it in 36 quarters since. The position peaked at $31.4M in Q4 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Willis Investment Counsel held 151,800 shares of Quest Diagnostics worth $29.7M as of Q1 2026.
- Willis Investment Counsel left its Quest Diagnostics share count unchanged in Q1 2026.
- Quest Diagnostics made up 1.62% of Willis Investment Counsel's portfolio in Q1 2026, its #22 holding.
- Willis Investment Counsel first reported a position in Quest Diagnostics in Q3 2015 and has held it in 36 quarters since.
- Willis Investment Counsel's Quest Diagnostics position peaked at $31.4M in Q4 2021.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Willis Investment Counsel's 13F filing for Q1 2026, filed 5 May 2026.